Full-Time

Product Manager

Enterprise Imaging

Updated on 8/21/2026

Aegis Ventures

Aegis Ventures

11-50 employees

Launches AI-driven health tech companies

Compensation Overview

$160k - $180k/yr

+ Equity

Remote in USA + 2 more

More locations: Irvine, CA, USA | Columbus, OH, USA

Remote

Bachelor's

Category
Product (1)
Required Skills
Agile
Product Management

Get referred to Aegis Ventures

See people who can refer or advise you

Requirements
  • 5+ years of product management experience.
  • Experience building enterprise healthcare software products.
  • Strong understanding of enterprise imaging workflows, including PACS, VNA, DICOM, and image exchange.
  • Experience leading products from concept through commercial launch.
  • Ability to translate complex customer workflows into intuitive software solutions.
  • Excellent communication and stakeholder management skills.
  • Experience working closely with engineering teams in Agile development environments.
  • Bachelor’s degree.
  • Experience with healthcare interoperability technologies including DICOM, HL7, and FHIR.
  • Experience in cloud-based SaaS healthcare platforms.
  • Familiarity with healthcare privacy, security, and compliance requirements.
  • Experience working directly with radiology departments, imaging centers, or health systems.
Responsibilities
  • Own the product vision, roadmap, and execution for Avandra’s Enterprise Imaging portfolio.
  • Define and prioritize initiatives that expand digital image exchange capabilities while strengthening physical media solutions.
  • Develop products that simplify how imaging moves between providers, patients, and healthcare organizations.
  • Identify market opportunities and customer needs that differentiate Avandra in the imaging ecosystem.
  • Lead products from concept through launch in collaboration with engineering, design, sales, customer success, and executive leadership.
  • Write product requirements and user stories that translate customer problems into actionable engineering work.
  • Balance customer requests, technical constraints, and business priorities when making roadmap decisions.
  • Partner with engineering throughout development to ensure successful delivery and product quality.
  • Meet with health systems, imaging centers, and strategic partners to understand workflows and emerging market needs.
  • Gather customer feedback through interviews, product demonstrations, and beta programs.
  • Monitor competitive offerings and industry trends across enterprise imaging and healthcare interoperability.
  • Represent Avandra at customer meetings and industry conferences.
  • Develop capabilities that make it easier for healthcare organizations to participate in Avandra’s imaging data network.
  • Work cross-functionally to ensure image exchange products create long-term strategic value across clinical and data-driven use cases.
  • Partner with internal stakeholders to identify platform capabilities that benefit providers, researchers, and life sciences organizations.
  • Partner with marketing and sales to develop product positioning, messaging, pricing support, and go-to-market plans.
  • Support customer enablement, product documentation, training, and launch readiness.
  • Define success metrics and continuously measure product adoption and customer satisfaction.
Desired Qualifications
  • Experience with healthcare interoperability technologies including DICOM, HL7, and FHIR.
  • Experience in cloud-based SaaS healthcare platforms.
  • Familiarity with healthcare privacy, security, and compliance requirements.
  • Experience working directly with radiology departments, imaging centers, or health systems.

Aegis Ventures is a startup studio that partners with entrepreneurs and industry leaders to originate, launch, and scale new companies focused on AI and health tech. It operates a platform that combines market-shaping ideas, permanent growth capital, and ambitious people to identify opportunities, fund them long-term, and provide hands-on operational support. Unlike traditional funds, it creates companies in-house with a built-in path to rapid growth, with a strong emphasis on transforming healthcare quality, access, and cost. Its goal is to build companies capable of vast impact by using technology to improve health outcomes and societal wellbeing.

Company Size

11-50

Company Stage

N/A

Total Funding

$33.1M

Headquarters

New York City, New York

Founded

2020

Get referred to Aegis Ventures

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • April 2026 Wavelet $7M seed expands Aegis into fetal medicine commercialization.
  • May 2026 whitepaper and Bunny Ellerin hire signal aggressive platform-building in medtech AI.
  • Portfolio now includes Ascertain, Avandra, Caregentic, Hume, Optain, and Wavelet, broadening optionality.

What critics are saying

  • Ascertain launched in 2022; five companies still concentrate value in unproven early-stage bets.
  • Wavelet needs regulatory clearance and hospital adoption before revenue, delaying scale.
  • If Northwell or Yale withdraws, Aegis loses its core sourcing and distribution moat.

What makes Aegis Ventures unique

  • Northwell partnership plus permanent growth capital gives proprietary clinical distribution.
  • Yale relationship and 2026 Wavelet seed show university-to-market commercialization engine.
  • Five launched AI health companies and $200M+ portfolio capital prove repeatable studio model.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Flexible Work Hours

Company Equity

Wellness Program

Mental Health Support

Company News

Yahoo Finance
Apr 14th, 2026
Yale-born fetal brain monitoring startup Wavelet secures $7M to prevent birth injuries

Wavelet Medical has secured $7 million in seed funding from Aegis Ventures to commercialise the first non-invasive, AI-powered fetal electroencephalography monitoring platform. The technology, developed at Yale, aims to detect fetal brain distress in real time and prevent avoidable brain injury at birth. Founded by Liz Golden, Dr Emily Lee and Dr Jose Cortes-Briones, Wavelet uses EEG captured through the mother's abdomen and reconstructed with AI algorithms to identify neurological distress, addressing limitations of traditional fetal heart rate monitoring, which is indeterminate in up to 85% of births. The platform targets a significant problem: over 35,000 infants suffer birth-related brain injuries annually in the US alone. Wavelet's partnership with Aegis Ventures will accelerate product development, clinical adoption and commercialisation of the technology.

PR Newswire
Apr 14th, 2026
Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine

/PRNewswire/ -- A breakthrough in fetal brain monitoring developed at Yale is moving from laboratory discovery to global commercialization through a pivotal...

Teknovation.biz
Nov 25th, 2024
News & Notes | Foundersforge Joins Village Capital’S Resource Iii Program For Entrepreneur Support Organizations

From Knoxville: The Knoxville Technology Council is asking local business representatives to complete its latest KTech Pulse 2024 Survey. Noting that the organization wants to get the pulse of Knoxville-area... The post News Notes | FoundersForge joins Village Capitals Resource III Program for Entrepreneur Support Organizations appeared first on Teknovation.biz.

Aegis Ventures
Oct 10th, 2023
Our Focus

We are driven by the mission to build companies that solve society's greatest problems, informed by the belief that the nexus of profits and purpose will create a virtuous cycle of impact that moves the world forward.

PR Newswire
Aug 22nd, 2023
Ascertain Announces Leadership Team With Appointment Of Ceo Mark Michalski, M.D. And Executive Chairman Gregg Fergus

Michalski, an Amazon alum, and Fergus, ex-CEO of 4Catalyzer, will lead the company creation platform building AI applications in healthcare.NEW YORK, Aug. 22, 2023 /PRNewswire/ -- Ascertain, a healthcare AI company creation platform, today announced the formation of its leadership team with the appointment of CEO Mark Michalski, M.D. and Executive Chairman, Gregg Fergus. Michalski and Fergus will lead Ascertain in its mission to merge deep technical, operational, and clinical expertise to deliver high-quality, equitable, and affordable healthcare.Michalski brings two decades of executive leadership experience to Ascertain. Prior to Ascertain, Michalski led strategic development for healthcare and life sciences at Amazon, was Founding Executive Director at Mass General Brigham/Harvard's Center for Clinical Data Science, and served as President and CMO of two publicly traded companies - Butterfly Network and Hyperfine Research. He is a board-certified radiologist and completed his medical training at Yale and Stanford.Fergus and Michalski met and collaborated closely at the venture studio 4Catalyzer where Fergus was CEO, launching several leading healthcare companies including Butterfly Network, Hyperfine Research, AI Therapeutics, and Quantum Si